Showing results (31-40 of 48) with videos related to
Sort By:
Pageof 5
Lancet (London, England)|January 23, 1993
Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone-marrow transplantationA P Schwarer, Y Z Jiang, P A Brookes, et al.British Journal of Haematology|July 1, 1992
Relapse into blast crisis following bone marrow transplantation for chronic phase chronic myeloid leukaemia: a report of five casesJ O Cullis, D I Marks, A P Schwarer, et al.Transplantation|December 15, 1994
Comparison of helper and cytotoxic antirecipient T cell frequencies in unrelated bone marrow transplantationA P Schwarer, Y Z Jiang, S Deacock, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 14, 2006
A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignanciesE J Bow, C Rotstein, G A Noskin, et al.Bone Marrow Transplantation|August 11, 2001
Allogeneic haemopoietic cell transplants in Australia, 1996--a multi-centre retrospective comparison of the use of peripheral blood stem cells with bone marrowI Nivison-Smith, K F Bradstock, J Szer, et al.Annals of Internal Medicine|September 19, 2001
Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trialM Boogaerts, D J Winston, E J Bow, et al.British Journal of Haematology|July 1, 1992
HLA-identical sibling donor bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: influence of GVHD prophylaxis on outcomeD I Marks, T P Hughes, R Szydlo, et al.British Journal of Haematology|December 3, 1999
Factors affecting the outcome of allogeneic bone marrow transplantation for adult patients with refractory or relapsed acute leukaemiaA P Grigg, J Szer, J Beresford, et al.Bone Marrow Transplantation|January 1, 1993
Matched unrelated donor bone marrow transplantation for chronic myeloid leukaemia in chronic phase: comparison of ex vivo and in vivo T-cell depletionJ O Cullis, R M Szydlo, N C Cross, et al.Bone Marrow Transplantation|November 24, 2004
Optimal scheduling to reduce morbidity of involved field radiotherapy with transplantation for lymphomas: a prospective Australasian Leukaemia and Lymphoma Group StudyA Wirth, H M Prince, M Wolf, et al.Pageof 5